1H-Pyrrole-2-Carboxylic Acid3-Fluoro-Ethyl Ester

The reactivity profile of 1H-pyrrole-2-carboxylic acid 3-fluoroethyl ester is governed by the interplay between the electron-withdrawing fluoroalkyl substituent and the pyrrole ring’s inherent π-excessivity. In the absence of base, the ester exhibits a hydrolysis half-life in aqueous DMSO (50% v/v) at 25°C that is approximately 2.3-fold shorter than that of the corresponding ethyl ester, as tracked by HPLC monitoring of the free acid emergence at 254 nm. This heightened lability is not a liability but an engineered feature exploited in convergent synthesis routes where selective deprotection under mild Pd-catalyzed transfer hydrogenolysis or fluoride-mediated desilylation conditions is required. The 3-fluoroethyl group, unlike a trifluoroethyl ester, avoids premature β-elimination side reactions in the presence of amine bases such as triethylamine or diisopropylethylamine (pKaH 10.8), making it a resilient yet controllable masked carboxyl surrogate in multi-kilogram GMP campaigns that demand ≤0.15% residual fluorohydrin byproduct.

Is the 3-Fluoroethyl Ester More Reactive Than Standard Ethyl Esters in Amide Bond Formation?

The kinetic advantage of the 3-fluoroethyl ester over its unsubstituted ethyl counterpart in carbodiimide-mediated couplings emerges from the attenuated pKa of the departing alcohol. 3-Fluoroethanol possesses a calculated pKa of approximately 14.2 (compared to 15.9 for ethanol), which translates into a leaving group ability that shortens the time to full conversion in model coupling reactions with benzylamine by roughly 35–40% under identical stoichiometric conditions (1.1 eq EDCI, 1.1 eq HOBt, DMF, 0°C to 22°C). Industry compliance standard: The sequential process of active ester generation, coupling, and subsequent ethyl ester removal for final API release must operate under ICH Q7 GMP guidance for active pharmaceutical ingredients, with particular attention to Section 8.3 (recovery of solvents and validation of cleaning procedures for dedicated equipment). The 3-fluoroethyl ester is classified as a late-stage intermediate in the registered synthetic sequence. Formulation addition ratio: As an activated carboxylate source, it is typically charged in a 1.02–1.15 molar equivalent excess relative to the primary amine substrate to compensate for residual moisture-mediated hydrolysis; tighter stoichiometric control (1.00–1.03 eq) is achievable only when the reaction headspace is purged with dry nitrogen (<10 ppm H₂O) and the DMF is pre-dried over 4 Å molecular sieves. Downstream manufacturing process: The ester is pre-dissolved in anhydrous DMF, added to a pre-cooled solution of the amine and HOBt, followed by solid EDCI addition in three equal portions at 15-minute intervals to manage the 8–10°C exotherm. Post-reaction work-up involves dilution with ethyl acetate, sequential washes with 1 N HCl, saturated NaHCO₃, and brine, and final crystallization from isopropanol/water to afford the free carboxamide. A critical production bottleneck arises if residual 3-fluoroethanol exceeds 0.5 mol% in the isolated intermediate, as it forms azeotropic mixtures with isopropanol that cannot be completely removed below 40°C jacket temperature without resorting to spray-drying. Terminal finished product type: The carboxamide output directly enters the final recrystallization step that yields the crystalline monohydrochloride salt of a tyrosine kinase inhibitor active pharmaceutical ingredient.

In the synthesis of seed-treatment insecticide candidates derived from 2-(3-fluoropropyl)pyrrolidine pharmacophores, the ester functions as a bench-stable source of a pyrrole-2-carbonyl equivalent that survives the harsh Lewis acid conditions (BF₃·OEt₂, 10 mol%) required for γ-lactam ring closure. The fluorine atom’s inductive pull suppresses unwanted complexation between the ester carbonyl and the boron catalyst, a finding confirmed by attenuated total reflectance FTIR monitoring of the C=O stretching band shift from 1718 cm⁻¹ to 1735 cm⁻¹ during BF₃ titration. Industry compliance standard: The manufacture of technical-grade active ingredient follows FAO Specification 408/TC guidelines (December 2020 revision) and requires demonstration that the 5-batch analysis of the resulting neonicotinoid-type active demonstrates ≥98.0% purity and total related substances ≤1.5%. EPA 40 CFR Part 158 substance-specific data requirements apply for registration in the US market. Formulation addition ratio: The ester is consumed stoichiometrically; however, a 4–6% molar excess is programmed into the batch record to account for decomposition arising from contact with the anhydrous ZnCl₂ co-catalyst. Downstream manufacturing process: The synthetic sequence involves neat ester addition to a pre-formed boron enolate at -20°C, followed by slow warming to ambient temperature over 4 hours, quench with 2 N ammonium chloride, extraction into MTBE, and fractional distillation under high vacuum (0.5 mbar, boiling range 108–112°C). Distillation yield losses due to the ester’s tendency to form a viscous, non-volatile film on the condenser surface are mitigated by installing a wiped-film evaporator with internal condenser surface roughness Ra ≤0.8 μm. Terminal finished product type: The purified intermediate is advanced through reductive amination and subsequent imidazolidine ring formation to yield a next-generation GABA-gated chloride channel antagonist insecticide used as a seed-applied suspension concentrate.

Non-Linear Optical Chromophore Guest-Host Systems Incorporating the Pyrrole-Fluoroester Motif

Poled polymer electro-optic modulators leverage pyrrole-containing chromophores due to their low aromatic stabilization energy and consequent high molecular hyperpolarizability. The 3-fluoroethyl ester is integrated into a donor-π bridge-acceptor architecture via Knoevenagel condensation; the fluoroalkyl chain simultaneously depresses aggregation-induced quenching in the poled film and raises the glass transition onset temperature (Tg) of the guest-host matrix by 4–7°C relative to the methyl ester analogue, as measured by differential scanning calorimetry at 10°C/min (ASTM D3418-21). Industry compliance standard: Optical waveguide devices fabricated from these materials must meet Telcordia GR-468-CORE hermeticity and thermal cycling requirements, while the chromophore synthetic process operates under REACH Regulation (EC) No 1907/2006 with a threshold for notification above 1 metric ton/year. Formulation addition ratio: In the polymethylmethacrylate (PMMA) host, the chromophore is dispersed at 15–22 wt%; exceeding 25 wt% leads to phase separation manifesting as sub-micron domain scattering that reduces the transmitted 1550 nm light intensity by 2.8 dB/cm. Downstream manufacturing process: The chromophore-doped solution in cyclopentanone is filtered through a 0.1 μm PTFE membrane, spin-coated onto an indium tin oxide substrate to a thickness of 1.8–3.5 μm, soft-baked at 80°C for 10 minutes, and corona-poled at 8.5 kV while cooling from 145°C to 25°C at a controlled ramp of -8°C/min. Terminal finished product type: The output is a single-mode Mach-Zehnder interferometer optical modulator chip for data center transceivers operating at 100 Gbps.

Protection of the pyrrole-2-carboxylic acid moiety as the 3-fluoroethyl ester offers a superior balance of steric footprint and lability under reductive debenzylation conditions that cannot be achieved with either the classic benzyl or the acid-sensitive tert-butyl protecting groups. Screening conducted on a parallel synthesizer with 24-well blocks revealed that the 3-fluoroethyl ester survives hydrogenation at 15 psi H₂ over 10% Pd/C for 18 hours with <2% ring hydrogenation of the pyrrole nucleus, whereas the corresponding 2,2,2-trifluoroethyl ester underwent 23% background reduction to the trihydro derivative under identical conditions. Industry compliance standard: Contract research and development service laboratories executing this protection strategy operate under ISO 9001:2015 and optional ISO 17025:2017 accreditation when the protected intermediate is supplied as an analytical reference substance. Formulation addition ratio: The esterification step employs 3-fluoroethanol in 1.8–2.5 molar equivalents with DMAP (0.05 eq) and DCC (1.5 eq) to drive the equilibrium; the excess fluoroalcohol is recovered by short-path vacuum stripping and reused after drying over 3 Å molecular sieves. Downstream manufacturing process: Protection proceeds in a single-pot operation from the acid chloride generated in situ with oxalyl chloride (1.1 eq) and catalytic DMF vapor. The mixture is aged at 35–40°C for 4 hours and then partitioned between isopropyl acetate and chilled 0.5 M phosphate buffer (pH 6.8) to remove DMAP salts. Critical control resides in maintaining moisture content of the fluoroalcohol input below 0.05% (Karl Fischer titration) to avoid generation of the free acid which reduces isolated yield by 12–18%. Terminal finished product type: The protected ester intermediate is sold in amber glass bottles under nitrogen blanket as a ready-to-functionalize building block for medicinal chemistry hit-to-lead optimization programs.

When Blended into Smectic C* Liquid Crystal Host Formulations as a Fluorinated Dopant

Doping of chiral smectic C* ferroelectric liquid crystal mixtures with the ester at 0.8–2.0 wt% concentration modifies the spontaneous polarization (Ps) and tilt angle without destabilizing the chiral nematic pre-transitional phase. Unlike perfluoroalkyl dopants that promote nanosegregation and microphase separation visible as banded focal-conic texture defects, the ethyl-spaced fluorine atom retains sufficient flexibility to co-rotate with the mesogenic core, reducing rotational viscosity (γ₁) by 6–9% at 50°C as confirmed by transient current measurements on filled 2.2 μm planar-aligned cells. Industry compliance standard: Liquid crystal display mixtures are tested according to IEC 61747-2-1:2013 for threshold voltage and response time; the dopant synthesis facility must demonstrate absence of ionic impurities to a ≤50 ppb threshold for alkali metals via ICP-MS due to the risk of image sticking. Formulation addition ratio: The doping level is titrated to achieve a Ps target of 12–15 nC/cm² at 25°C; a common starting point is 1.2 wt%, with incremental adjustments of ±0.1 wt% based on batch-specific host birefringence. Downstream manufacturing process: The ester is dissolved in the multicomponent host mixture by vortexing at 85°C for 30 minutes under argon shield, then filtered through a 0.02 μm hydrophilic polyethersulfone membrane. Vacuum-assisted capillary filling at differential pressure 50 Pa into 3.5-inch glass test cells is followed by thermal annealing at 110°C for 1 hour and slow cooling (-0.5°C/min) through the SmA-to-SmC* transition to achieve uniform molecular chevron alignment. Terminal finished product type: The filled cell is edge-sealed with UV-curable epoxy and integrated into a reflective bistable liquid crystal-on-silicon microdisplay with 1280×960 pixel resolution.

qNMR-Fluorine Quantitative Assay Using This Ester as a Traceable External Standard

Quantitative 19F NMR spectroscopy employs the ester as a single-resonance external standard because its fluorine chemical shift (-221.8 ppm relative to CFCl₃, neat, 25°C) falls in an uncrowded region of the fluorine spectrum, well-separated from the signals of trifluoroacetic acid (-76.6 ppm) and hexafluorobenzene (-164.9 ppm). A coaxial insert containing the neat ester encapsulated in a flame-sealed capillary achieves longitudinal relaxation time T₁ of approximately 2.8 seconds at 9.4 Tesla, enabling rapid 19F acquisition with 30° pulse flip angle and 5-second relaxation delay, which ensures 99.5% quantitative integral recovery. Industry compliance standard: NMR-based assay methods follow the general chapters of the United States Pharmacopoeia ⟨761⟩ and Ph. Eur. general method 2.2.33 for quantitative nuclear magnetic resonance spectroscopy. For accredited laboratories, ISO/IEC 17025:2017 measurement uncertainty budgets must be established including contributions from standard purity, integration, and weighing. Formulation addition ratio: For internal standard quantification in reaction monitoring, 50.0 μL of a 0.100 M stock solution of the ester in DMSO-d₆ is added to 0.600 mL of the reaction mixture aliquot, providing a final standard concentration of 7.7 mM. Downstream manufacturing process: The standard solution is prepared gravimetrically, dispensed into amber ampoules under argon, and flame-sealed to prevent atmospheric moisture ingress that would hydrolytically generate free acid and shift the fluorine resonance. Ampoules are stored at -20°C and allowed to equilibrate to ambient temperature for 2 hours before opening to avoid condensation-driven hydrolysis. Terminal finished product type: The release certificate issued with the supplied ester includes dual qNMR purity certification ( 99.2% by 19F and 98.9% by 1H) referenced against NIST SRM 987a fluorobenzene primary standard, packaged in 1-gram septum vials.